Walsh & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.12K Buy
+50
New +$3.16K ﹤0.01% 233

Other funds holding BMY

Walsh & Associates's BMY Position: Q3 2026 in Review

Walsh & Associates opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 50 shares worth $3.12K. The stake represents ﹤0.01% of the portfolio and ranks #233 among its holdings.

2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Walsh & Associates held 50 shares of Bristol-Myers Squibb worth $3.12K as of Q3 2026.
  • Bristol-Myers Squibb was a new Walsh & Associates position in Q3 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #233 holding.
  • 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.